Suzuki, R., Sakamaki, H., Inubashiri, N., Makishima, M., Aoki, H., Yoshida, E., Inoue, H., Kawasaki, A., Shibahara, H., Murata, T., Fuji, S. (2025). Cost-effectiveness analysis of mosunetuzumab compared with novel alternative immunotherapies in patients with third-line or later relapsed/refractory follicular lymphoma in Japan. Blood. https://doi.org/10.1182/blood-2025-6178